S&P 500   5,078.18 (+0.17%)
DOW   38,972.41 (-0.25%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
S&P 500   5,078.18 (+0.17%)
DOW   38,972.41 (-0.25%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
S&P 500   5,078.18 (+0.17%)
DOW   38,972.41 (-0.25%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
S&P 500   5,078.18 (+0.17%)
DOW   38,972.41 (-0.25%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
NYSEARCA:BBP

Virtus LifeSci Biotech Products ETF (BBP) Price, Holdings, & News

$63.33
+2.07 (+3.38%)
(As of 02/27/2024 ET)
Today's Range
$61.82
$63.33
50-Day Range
$55.03
$60.81
52-Week Range
$45.00
$63.25
Volume
727 shs
Average Volume
3,744 shs
Market Capitalization
$22.17 million
Assets Under Management
$21.35 million
Dividend Yield
0.00%
Net Expense Ratio
0.79%

About Virtus LifeSci Biotech Products ETF

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.

BBP Stock Price History

BBP ETF News Headlines

iShares Neuroscience and Healthcare ETF
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Key Takeaways From Virtus Inv Analyst Ratings
Two ETF Plays for a Rebound in Biotech Stocks
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Biotech Wins Last Week: 5 Best ETFs
See More Headlines
Receive BBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Products ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Virtus
Fund Name
Virtus LifeSci Biotech Products ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:BBP
Inception Date
12/16/2014
Fund Manager
Matthew B. Brown, Seth Kadushin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
LifeSci Biotechnology Products Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
57

Fund Statistics

Assets Under Management
$21.35 million
Average Daily Volume
$365.20
Discount/Premium
0.25%

Administrator, Advisor and Custodian

Administrator
Virtus ETF Solutions, LLC
Advisor
Virtus ETF Advisers LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
ETF Distributors LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Beta
0.73
Creation Unit
50,000
Creation Fee
$500.00
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Virtus LifeSci Biotech Products ETF Expenses

TypeBBPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.79%0.57%0.54%0.50%0.51%
Other Expenses0.00%0.40%0.55%0.64%0.58%
Total Expense0.79%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.69%-0.57%
Net Expense0.79%0.61%0.60%0.57%0.58%

Virtus LifeSci Biotech Products ETF (BBP) Holdings & Exposure















BBP ETF - Frequently Asked Questions

How have BBP shares performed in 2024?

Virtus LifeSci Biotech Products ETF's stock was trading at $58.09 at the start of the year. Since then, BBP shares have increased by 8.7% and is now trading at $63.13.
View the best growth stocks for 2024 here
.

What does BBP invest in?

Virtus LifeSci Biotech Products ETF is a equity fund issued by Virtus. BBP focuses on health care investments and follows the LifeSci Biotechnology Products Index. The fund's investments total to approximately $21.35 million assets under management.

What is the management fee for Virtus LifeSci Biotech Products ETF?

Virtus LifeSci Biotech Products ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for BBP is 0.79%.

What other stocks do shareholders of Virtus LifeSci Biotech Products ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Virtus LifeSci Biotech Products ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Intel (INTC), Micron Technology (MU), Virtus LifeSci Biotech Clinical Trials ETF (BBC), Quest Diagnostics (DGX), Pfizer (PFE), Simon Property Group (SPG) and Cidara Therapeutics (CDTX).

How do I buy shares of Virtus LifeSci Biotech Products ETF?

Shares of BBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:BBP) was last updated on 2/27/2024 by MarketBeat.com Staff